Skip to main content
. 2016 Mar 8;5(3):e292. doi: 10.1038/mtna.2016.1

Figure 1.

Figure 1

WST-1 assay of Li-pshRNA. WST-1 assay was performed to confirm cell viability after treatment with Li-pshRNA. There was no significant difference in cell viability among the treatment groups (n = 4, **P < 0.01). ANGPTL2, angiopoietin-like protein 2; Li-pshRNA, proline-modified short hairpin RNA wrapped with liposome.